Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 102,600
-400 (-0.39%)
Jun 12, 2026, 3:30 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 8.69 trillion as of June 12, 2026. Its market cap has increased by 214.12% in one year.
Market Cap
8.69T
Enterprise Value
8.64T
Revenue
5.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
102,600.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 8.69T, an increase of 237.21%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 8.69T | 31.24% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 16.87T |
| Samsung Epis Holdings | 10.43T |
| SK Biopharmaceuticals | 6.77T |
| HLB Co., Ltd. | 6.45T |
| Peptron | 5.64T |
| LigaChem Biosciences | 4.82T |
| D&D Pharmatech | 3.81T |
| Voronoi | 3.56T |